Summary
Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo’s private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Source: finance.yahoo.com
Related posts:
Stocks wobble amid new economic warnings: Stock market news today
Florida Startup Offers Solution To Decades-Old Pipeline Puzzle
Stocks rally, dollar droops in abbreviated session
Elon Musk’s Latest Mission: Rev Up the Electricity Industry
4 simple things to do with your money now, so you start 2023 off on the right financial footing